Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 49 (1) , 127-135
- https://doi.org/10.1194/jlr.m700258-jlr200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP)Journal of Biological Chemistry, 2003
- Markedly Elevated Lipid Transfer Inhibitor Protein in Hypercholesterolemic Subjects Is Mitigated by Plasma Triglyceride LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Lipid Transfer Inhibitor Protein Defines the Participation of Lipoproteins in Lipid Transfer ReactionsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Molecular Cloning and Expression of Lipid Transfer Inhibitor Protein Reveals Its Identity with Apolipoprotein FPublished by Elsevier ,1999
- Lipid Transfer Inhibitor Protein Activity Deficiency in Normolipidemic Uremic Patients on Continuous Ambulatory Peritoneal DialysisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- PLASMA LIPID TRANSFER PROTEINSAnnual Review of Biochemistry, 1995
- Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.Journal of Clinical Investigation, 1991
- Interaction of lipid transfer protein with plasma lipoproteins and cell membranesCellular and Molecular Life Sciences, 1990